[1]
“Neoadjuvant Chemotherapy for Breast Cancer: Moving Beyond Pathological Complete Response in the Molecular Age”, ama, vol. 50, no. 1, pp. 88–109, May 2021, doi: 10.5644/ama2006-124.328.